Characterisation of carbapenem-resistance mechanisms in clinical Pseudomonas aeruginosa isolates recovered in a Spanish hospital. 2017

Vanesa Estepa, and Beatriz Rojo-Bezares, and Jose Manuel Azcona-Gutiérrez, and Inés Olarte, and Carmen Torres, and Yolanda Sáenz
Área de Bioquímica y Biología Molecular, Universidad de La Rioja, Logroño, España.

BACKGROUND Carbapenems are the beta-lactam antibiotics with the best spectrum of activity in the treatment of Pseudomonas aeruginosa infections. The objective of this study was to molecularly characterise a collection of carbapenem-resistant P. aeruginosa isolates (PARC). METHODS A total of 85 PARC isolates were recovered from 60patients in the Hospital San Pedro, Logroño (period 2008-2011). Clonal relationship was determined using pulsed-field gel electrophoresis (PFGE), susceptibility testing to 15anti-pseudomonal agents was performed using the disk diffusion method, and alterations in oprD, characterisation of integrons and molecular typing (MLST) using PCR and sequencing. RESULTS The 85 PARC were classified into 35 different PFGE profiles. Of the 61selected strains from 60patients all of them were multiresistant, although none of them showed a carbapenemase phenotype. High polymorphism was detected in OprD, emphasising that 59% of the strains had a premature stop codon. ISPa1328 and ISPsp4 insertion sequences truncated oprD gene into 2 strains (GenBank KF517097 and KF517098). Two-thirds (67%) of the strains showed class 1 integrons with genes encoding aminoglycoside modifying enzymes, and 2 of them carried a new integron: aac(3)-Ia+aadA1h, named In272, GenBank GQ144317. Four sequence types were detected (Strain Nos.): ST175 (35), ST308 (3), ST235 (2), and ST639 (1). CONCLUSIONS Multidrug resistance, high polymorphism in oprD, a high percentage of integrons, moderate clonal relationship of strains, and the high epidemic dissemination of high-risk clones are clinical aspects of great concern in order to eradicate the spread of PARC.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D005260 Female Females
D006761 Hospitals Institutions with an organized medical staff which provide medical care to patients. Hospital
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

Vanesa Estepa, and Beatriz Rojo-Bezares, and Jose Manuel Azcona-Gutiérrez, and Inés Olarte, and Carmen Torres, and Yolanda Sáenz
February 2001, Antimicrobial agents and chemotherapy,
Vanesa Estepa, and Beatriz Rojo-Bezares, and Jose Manuel Azcona-Gutiérrez, and Inés Olarte, and Carmen Torres, and Yolanda Sáenz
December 2007, Antimicrobial agents and chemotherapy,
Vanesa Estepa, and Beatriz Rojo-Bezares, and Jose Manuel Azcona-Gutiérrez, and Inés Olarte, and Carmen Torres, and Yolanda Sáenz
June 2015, Microbial drug resistance (Larchmont, N.Y.),
Vanesa Estepa, and Beatriz Rojo-Bezares, and Jose Manuel Azcona-Gutiérrez, and Inés Olarte, and Carmen Torres, and Yolanda Sáenz
August 2007, Journal of chemotherapy (Florence, Italy),
Vanesa Estepa, and Beatriz Rojo-Bezares, and Jose Manuel Azcona-Gutiérrez, and Inés Olarte, and Carmen Torres, and Yolanda Sáenz
August 2019, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Vanesa Estepa, and Beatriz Rojo-Bezares, and Jose Manuel Azcona-Gutiérrez, and Inés Olarte, and Carmen Torres, and Yolanda Sáenz
September 2021, Journal of global antimicrobial resistance,
Vanesa Estepa, and Beatriz Rojo-Bezares, and Jose Manuel Azcona-Gutiérrez, and Inés Olarte, and Carmen Torres, and Yolanda Sáenz
January 2009, Scandinavian journal of infectious diseases,
Vanesa Estepa, and Beatriz Rojo-Bezares, and Jose Manuel Azcona-Gutiérrez, and Inés Olarte, and Carmen Torres, and Yolanda Sáenz
January 2009, Pathologie-biologie,
Vanesa Estepa, and Beatriz Rojo-Bezares, and Jose Manuel Azcona-Gutiérrez, and Inés Olarte, and Carmen Torres, and Yolanda Sáenz
January 2018, Infection and drug resistance,
Vanesa Estepa, and Beatriz Rojo-Bezares, and Jose Manuel Azcona-Gutiérrez, and Inés Olarte, and Carmen Torres, and Yolanda Sáenz
August 2001, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
Copied contents to your clipboard!